Lisa Ricciardi has been appointed CEO of Cambridge, MA-based Suono Bio. Founding CEO Carl Schoellhammer will shift to chief operating officer and board member. Ricciardi’s experience includes various roles at companies such as Pfizer (NYSE: [[ticker:PFE]]), Medco, and Foundation Medicine. Suono, an MIT spinout, is developing technology that uses ultrasound to improve drug delivery.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
